Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors

Diffuse-type gastric carcinomas (DGC) exhibit more aggressive progression and poorer prognosis than intestinal-type and other gastric carcinomas. To identify potential therapeutic targets, we examined protein tyrosine phosphorylation in a panel of DGC and other gastric cancer cell lines. Protein tyr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Yamaguchi, Hideki, Takanashi, Miho, Yoshida, Nachi, Ito, Yuumi, Kamata, Reiko, Fukami, Kiyoko, Yanagihara, Kazuyoshi, Sakai, Ryuichi
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317844/
https://ncbi.nlm.nih.gov/pubmed/24612061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12387
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados